bioAffinity Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. 

CEO
Maria Zannes
CEOMaria Zannes
Employees
57
Employees57
Headquarters
San Antonio, Texas
HeadquartersSan Antonio, Texas
Founded
2014
Founded2014
Employees
57
Employees57

BIAF Key Statistics

Market cap
7.18M
Market cap7.18M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
Dividend yield
Average volume
208.11K
Average volume208.11K
High today
$1.73
High today$1.73
Low today
$1.57
Low today$1.57
Open price
$1.73
Open price$1.73
Volume
206.70K
Volume206.70K
52 Week high
$13.80
52 Week high$13.80
52 Week low
$0.693
52 Week low$0.693

Stock Snapshot

With a market cap of 7.18M, bioAffinity Technologies(BIAF) trades at $1.58. The stock has a price-to-earnings ratio of -0.15.

On 2026-06-08, bioAffinity Technologies(BIAF) stock traded between a low of $1.57 and a high of $1.73. Shares are currently priced at $1.58, which is +0.6% above the low and -8.7% below the high.

bioAffinity Technologies(BIAF) shares are trading with a volume of 206.7K, against a daily average of 208.11K.

During the past year, bioAffinity Technologies(BIAF) stock moved between $0.69 at its lowest and $13.80 at its peak.

During the past year, bioAffinity Technologies(BIAF) stock moved between $0.69 at its lowest and $13.80 at its peak.

BIAF News

TipRanks 6d
BioAffinity Technologies announces SAB to host webinar on CyPath Lung

bioAffinity Technologies (BIAF) announced the Society for Advanced Bronchoscopy, SAB, will host a webinar on CyPath Lung’s expanding role in pulmonary, oncology...

TipRanks 6d
bioAffinity Showcases CyPath Lung in Upcoming Clinical Webinar

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

People also own

Based on the portfolios of people who own BIAF. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.